173 related articles for article (PubMed ID: 28833476)
1. Angiotensin-converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment.
Kittana N
Fundam Clin Pharmacol; 2018 Feb; 32(1):14-25. PubMed ID: 28833476
[TBL] [Abstract][Full Text] [Related]
2. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
3. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Iwata M; Cowling RT; Yeo SJ; Greenberg B
J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
Patel VB; Lezutekong JN; Chen X; Oudit GY
Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
[TBL] [Abstract][Full Text] [Related]
5. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Patel VB; Zhong JC; Grant MB; Oudit GY
Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
7. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
8. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Chamsi-Pasha MA; Shao Z; Tang WH
Curr Heart Fail Rep; 2014 Mar; 11(1):58-63. PubMed ID: 24293035
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Ferreira AJ; Bader M; Santos RA
Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
[TBL] [Abstract][Full Text] [Related]
13. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
14. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
[TBL] [Abstract][Full Text] [Related]
15. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
[TBL] [Abstract][Full Text] [Related]
16. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
17. ACE2/Ang-(1-7) signaling and vascular remodeling.
Zhang Z; Chen L; Zhong J; Gao P; Oudit GY
Sci China Life Sci; 2014 Aug; 57(8):802-8. PubMed ID: 25104453
[TBL] [Abstract][Full Text] [Related]
18. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
Ahmadian E; Pennefather PS; Eftekhari A; Heidari R; Eghbal MA
Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1279-1288. PubMed ID: 27352778
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
Oudit GY; Penninger JM
Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
[TBL] [Abstract][Full Text] [Related]
20. Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts.
Lin CS; Pan CH; Wen CH; Yang TH; Kuan TC
Peptides; 2010 Jul; 31(7):1334-40. PubMed ID: 20347904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
